Trade PTHS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Pelthos Therapeutics Inc. (PTHS) is trading at US$21.90, down 2.36% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$97.66M. Over the past 52 weeks, PTHS has traded between US$18.19 and US$37.50. On Syfe you can trade PTHS with $0 commission and add it to your watchlist.
| Previous close | US$22.43 |
|---|---|
| Market cap | US$97.66M |
| 52-week range | US$18.19 – US$37.50 |
| Volume | 18.94K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Pelthos Therapeutics Inc.
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil. Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.
Year: 2024
Pelthos Therapeutics Added to Russell 3000E Growth, Microcap Indexes
Jun 30, 9:36 PM · MT Newswires
Oppenheimer Adjusts Price Target on Pelthos Therapeutics to $66 From $62, Maintains Outperform Rating
May 15, 1:09 PM · MT Newswires
Top Premarket Decliners
Apr 7, 11:46 AM · MT Newswires
Cantor Fitzgerald Initiates Coverage on Pelthos Therapeutics With Overweight Rating, $50 Price Target
Apr 1, 11:40 AM · MT Newswires
Pelthos Therapeutics Inc. (PTHS) stock is trading at US$21.90, -2.36% from the previous close of US$22.43.
The market cap for Pelthos Therapeutics Inc. (PTHS) stock is approximately US$97.66M.
The 52-week high for Pelthos Therapeutics Inc. (PTHS) stock is US$37.50.
The 52-week low for Pelthos Therapeutics Inc. (PTHS) stock is US$18.19.
Pelthos Therapeutics Inc. (PTHS) does not currently pay a dividend.
Stay on top of PTHS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
